The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for HY Kim


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
12
Identification of small-molecule compounds targeting the dishevelled PDZ domain by virtual screening and binding studies.EBI
Yonsei University
12
Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).EBI
Korea University of Science and Technology (Ust)
13
Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKß inhibitors.EBI
Yonsei University
7
Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.EBI
Korea Research Institute of Chemical Technology
20
Synthesis and biological evaluation of cyclic sulfamide derivatives as 11ß-hydroxysteroid dehydrogenase 1 inhibitors.EBI
TBA
8
BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens.EBI
Gyeongsang National University School of Medicine
27
Synthesis and 11ß hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group.EBI
Korea University
10
Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogens.EBI
University of Illinois At Chicago
1
Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates.EBI
Merck
14
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors.EBI
Merck
31
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology.EBI
Quantitative Biosciences
15
Discovery and Structure-Activity Relationships of Novel Template, Truncated 1'-Homologated Adenosine Derivatives as Pure Dual PPARγ/δ Modulators.EBI
Seoul National University
35
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy.EBI
Merck
3
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.EBI
Chonnam National University
1
Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer's disease treatment.EBI
Korea Institute of Science and Technology
9
Small molecules that protect against β-amyloid-induced cytotoxicity by inhibiting aggregation of β-amyloid.EBI
Korea Institute of Science and Technology
7
Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).EBI
Achillion Pharmaceuticals
42
Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereofBDB
Shanghai Institute of Materia Medica
15
Characterization of alpha1-adrenoceptor subtypes in the pig.BDB
Uppsala University